Publications

February 1999 (Revised October 2009)
Case

Royal Dutch/Shell in Nigeria (A)

By: Lynn S. Paine and Mihnea C. Moldoveanu

Working with Shell's country manager for Nigeria, the company's Committee of Managing Directors must decide how to respond to the Nigerian government's decision to impose the death sentence on Ken Saro-Wiwa and eight other leaders of a movement for the rights of the... View Details

Keywords: Ethics; Multinational Firms and Management; Courts and Trials; Rights; Corporate Social Responsibility and Impact; Business and Government Relations; Environmental Sustainability; Social Issues; Nigeria

2008
Chapter

The Evidence Does Not Speak for Itself: Expert Witnesses and the Organization of DNA-Typing Companies

By: Arthur A. Daemmrich

During the past 15 years, new biotechnology companies have promoted DNA typing as a sophisticated criminal and paternity identification technique. Private testing laboratories produce results that link individuals with crime scenes and fathers to their children.... View Details

Keywords: Governing Rules, Regulations, and Reforms; Courts and Trials; Organizational Structure; Practice; Genetics; Science-Based Business; Trust; Commercialization; Vertical Integration

19 May 2016
Research Event

Crowdsourcing, Patent Trolls, and Other Research Insights Highlighted at Harvard Business School Symposium

dispute to court can be an expensive proposition. Cohen shared an example: Lumen View Technology, which had initiated patent lawsuits in the past against numerous companies, sued FindTheBest and several... View Details

Keywords: by Dina Gerdeman & Carmen Nobel

Incentives for Bad Science

Randomized controlled trials (RCTs) inform medical practice, health care delivery, follow-on research, regulation, and health policy. Yet, many RCTs are inadequately randomized, blinded, and reported. To analyze scientists' and firms' incentives to meet clinical trial... View Details

20 Aug 2014
News

Yes, patent trolls go out of their way to target rich companies

15 Jul 2022
News

The Right Step: Q+A With Rakoh Founder Raphael Kohlberg (MBA 2018)

15 Dec 2015
News

The Year in Ideas 2015

From social media to the grocery store to the corner office and all the way to the stratosphere, the research and entrepreneurial adventures HBS faculty, doctoral students and... View Details

Keywords: Julia Hanna, Christine Lejeune, Dan Morrell, and April White

November 2009 (Revised March 2010)
Case

Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story

By: Richard G. Hamermesh, Raju Kucherlapati and Rachel Gordon

In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had... View Details

Keywords: Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Marketing Strategy; Product Positioning; Genetics; Biotechnology Industry; Europe; United States

June 2010
Case

Playa Dorada Tennis Club: Expansion Strategy

By: W. Earl Sasser Jr. and Brent Kazan

Playa Dorada Beach & Resort in Boca Raton, Florida, faces a growing seasonal demand for tennis services. The number of guests is expected to double in the next few years, and while the tennis facilities are a popular and well-promoted amenity at the resort, court space... View Details

Keywords: Service Operations; Planning; Price; Expansion; Tourism Industry; Accommodations Industry; Travel Industry; Florida

16 Feb 2021
Blog Post

The Rise of The Sixes: Interview with CEO and Founder Franci Girard

change, Girard’s next step was off the court and onto Wall Street as a Prime Brokerage Associate at Goldman Sachs. “While at Goldman Sachs, I knew I wanted something more entrepreneurial for my career,” said... View Details

Keywords: Entrepreneurship; Consumer Products / Retail

December 2003 (Revised August 2006)
Background Note

Grutter v. Bollinger: A Synopsis

By: Lynn S. Paine

In June 2003, the U.S. Supreme Court announced its decision in Grutter v. Bollinger, upholding the principle of affirmative action in university admissions, which had been challenged as a violation of the U.S. Constitution's Fourteenth Amendment. This case includes... View Details

Keywords: Lawsuits and Litigation

05 Jul 2012
News

What Now? Health Care After the Supreme Court's Decision

February 2024
Case

Compass Pathways: Pioneering Psychedelic Treatment

By: Tiona Zuzul, Kisha Lashley and Gamze Yucaoglu

This case follows Compass Pathways, a pioneering company developing treatment for depression based on psilocybin, the compound found in ‘magic mushrooms.’ Psilocybin was a federally illegal substance in the U.S., and a “Schedule I” drug, defined as a drug “with no... View Details

Keywords: Commercialization; Corporate Strategy; Competitive Strategy; Product Launch; Health Testing and Trials; Research and Development; Laws and Statutes; Pharmaceutical Industry; Europe; United States; United Kingdom

13 Oct 2015
Research & Ideas

Does Business Get Done the Same Way in Emerging and Developed Countries?

because the legal system and independent courts pressure government to be even handed. Q: Are there common traits among successful leaders in emerging markets? Are the executive skillsets they need to... View Details

Keywords: by Sean Silverthorne

Web

When Migrants and Locals Innovate Together, Communities Gain | Working Knowledge

contributions, Choudhury and Marinoni focused their research on the city of Tulsa, Oklahoma, which has been actively courting remote workers by offering a $10,000 stipend to those willing to stay for at... View Details

26 Oct 2017
Research Event

In an Era of 'Fake News,' What is the Future of Advertising and Publishing?

legislative bodies and courts are still wrestling with if and how to regulate technology that is not only unprecedented in their capabilities and... View Details

Keywords: by Jen Deaderick; Media & Broadcasting; Journalism & News

October 2002
Case

A Father's Love: Novazyme Pharmaceuticals, Inc.

By: Richard M.J. Bohmer and Bradley Campbell

John Crowley, CEO of Novazyme Pharmaceuticals, a start-up biotechnology firm developing an orphan drug to treat a rare lysosomal storage disorder from which his children suffer, must choose between a partnership and a buyout to have sufficient funds and support to get... View Details

Keywords: Technological Innovation; Business Startups; Partners and Partnerships; Financing and Loans; Governing Rules, Regulations, and Reforms; Sales; Price; Product Development; Motivation and Incentives; Decision Choices and Conditions; Biotechnology Industry; Pharmaceutical Industry

November 1993 (Revised June 1996)
Case

C.K. Coolidge, Inc. (A)

Coolidge (CKC), a chemical manufacturer, is being sued for patent infringement. Plaintiffs are the patent holder and its sole licensee, who is also a CKC competitor. An analyst at CKC has done breakeven decision analysis from CKC's perspective, balancing going to court... View Details

Keywords: Negotiation Preparation; Patents; Lawsuits and Litigation; Chemical Industry